CTLA4 and cancer: Meanwhile, studies of the tumor microenvironment using markers specific to immune cells revealed that various cancers can express a series of CD markers: CD36 [74–77], CD58 [78], CD70 [79–82], CD160 [83, 84], CD276 [85], CD320 [86, 87], and CD336 [88].